"Spectrum Pharmaceuticals has two approved and marketed drugs, FUSILEV (obtaining recent April 29th FDA approval for expanded use of the drug to treat advanced metastatic colon cancer) and ZEVALIN. However their focus at ASCO [18 maj] this year will likely be two drugs in late-stage development, Belinostat and Apaziquone."
http://www.investorvillage.com/smbd.asp?mb=569&mn=28056&pt=msg&mid=10441000
Sendt fra ProInvestor gruppen
http://www.investorvillage.com/smbd.asp?mb=569&mn=28056&pt=msg&mid=10441000
Sendt fra ProInvestor gruppen
